BCL2 and diffuse large B-cell lymphoma: To understand the genetic basis underlying MHG-DLBCL and its aggressive clinical behaviour, we used targeted sequencing to investigate 697 cases of DLBCL, particularly enriched for those with MYC/BCL2-DH(TH) (n = 62).